The market is likely to consolidate further, with the previous day's low acting as support. Below are some short-term trading ideas to consider.
Consolidation is likely to continue as long as the index trades below the downward-sloping resistance trendline. Below are some short-term trading ideas to consider.
Stocks to Watch, 26 Feb: Stocks like Sanofi India, KSB, Sanofi Consumer Healthcare India, Foseco India, Railway Finance Corporation,Shaily Engineering Plastics, Lupin, KFin Technologies, Emmvee Photovoltaic Power March will be in focsu on Februay 26.
The Mumbai-based firm has received a nod from the USFDA for its abbreviated new drug application for Brivaracetam Oral Solution (10 mg/mL)
The market is expected to consolidate with range-bound trading. Below are some short-term trading ideas to consider.
Stocks to Watch, 25 February: Stocks like Schaeffler India, Elantas Beck India ,HG Infra Engineering ,Indian Railway Finance Corporation, Aditya Infotech, Rail Vikas Nigam, Waaree Energies, Lupin, Hexaware Technologies, and Dr Reddy's Laboratories will be in focus on February 25.
ICICI Securities recommended hold rating on Lupin with a target price of Rs 2200 in its research report dated February 16, 2026.
Motilal Oswal recommended Neutral rating on Lupin with a target price of Rs 2360 in its research report dated February 14, 2026.
Stocks to Watch, 17 Feb: Stocks like JSW Infrastructure, Cochin Shipyard, Lupin, Texmaco Rail & Engineering, Highway Infrastructure, TVS Supply Chain Solutions, and Seamec will be in focus on February 17.
Prabhudas Lilladher recommended Accumulate rating on Lupin with a target price of Rs 2400 in its research report dated February 16, 2026.
Lupin said on Tuesday it agreed to a $90-million settlement with Japan's Astellas Pharma in a patent dispute over the bladder disorder drug Mirabegron, a move that allows it to continue selling the product in the United States
The market is expected to remain range-bound with an elevated VIX. Below are some short-term trading ideas to consider.
In the current market condition, key would be to stay highly selective, not short the markets too much, and stay invested in relatively stronger pockets, said Milan Vaishnav.
The consolidation is likely to continue following a 2.5 percent loss last week. Below are some short-term trading ideas to consider.
Stocks to Watch, 31 December: Stocks like Privi Speciality Chemicals, RITES, Bharat Forge, Power Grid Corporation of India, Titan Company, IFCI, InterGlobe Aviation, Taj GVK Hotels and Resorts, Apollo Techno Industries, and Admach Systems will be in focus on December 31.
Stocks to Watch, 30 December: Stocks like Lupin, Rail Vikas Nigam, Bharat Electronics, Indian Overseas Bank, Waaree Energies, Afcons Infrastructure, Nazara Technologies, Entero Healthcare Solutions, Honasa Consumer, Mangalam Drugs and Organics, Gujarat Kidney & Super Speciality, and Shyam Dhani Industries will be in focus on December 30.
Stocks to Watch, 19 December: Stocks like HCL Technologies, Bharti Airtel, GPT Infraprojects, Swiggy, Waaree Energies, Premier Energies, Niraj Cement Structurals, Biocon, Arisinfra Solutions, Lupin, InterGlobe Aviation, Mishra Dhatu Nigam, Shree Digvijay Cement Company, Ola Electric Mobility, and ICICI Prudential AMC will be in focus on December 19.
The market is expected to gain further strength if the benchmarks reclaim the 20-day SMA. Below are some short-term trading ideas to consider.
The trend is expected to remain in favour of the bulls despite consolidation. Below are some short-term trading ideas to consider.
Stocks to Watch, 24 November: Stocks like Tata Consultancy Services, Rail Vikas Nigam, Tata Power Company, HG Infra Engineering, Kalpataru Projects International, Natco Pharma, Lupin, Shilpa Medicare, IDBI Bank, Kotak Mahindra Bank, Tata Chemicals, Samavardhana Motherson International, and RNIT AI Solutions will be in focus on November 24.
Stocks to Watch, 17 November: Stocks like Max Healthcare Institute, V2 Retail, Narayana Hrudayala, GMR Power and Urban Infra, Ashoka Buildcon, Websol Energy System, TruAlt Bioenergy, IRB Infrastructure Developers, Alembic Pharmaceuticals, Lupin, and Maruti Suzuki India will be in focus on November 17.
The market trend remains upward, but it requires a strong and sustainable close above last week's high for further upward movement. Below are some short-term trading ideas to consider.
Overall, technical patterns suggest Bank Nifty is potentially entering the 3rd wave higher, said Ashish Kyal.
Prabhudas Lilladher is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 2400 in its research report dated November 10, 2025.
Deven Choksey is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 2404 in its research report dated November 13, 2025.